Cartesian Therapeutics, Inc. (RNAC) Earnings Per Share (EPS)
Cartesian Therapeutics, Inc. (RNAC) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -$1.22 |
| 2020-12-31 | -$20.40 |
| 2021-12-31 | -$6.60 |
| 2022-12-31 | $7.20 |
| 2023-12-31 | -$49.80 |
| 2024-12-31 | -$4.48 |
| 2025-12-31 | -$5.02 |
How RNAC compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | -$3.74 |
| RGNX | REGENXBIO Inc. | -$3.76 |
| CELC | Celcuity Inc. | -$3.79 |
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
These are five companies in the same sector as RNAC with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Cartesian Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("RNAC")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RNAC | $8.76 | -1.02% | 0.06M |
| 3 | ||||
| 4 | ||||
| 5 |